Postępy Dermatologii i Alergologii

Full text

4/2026 vol. 43
Original paper

Integrated multi-omics and experimental analyses identify JUNB as a candidate biomarker associated with immune-related processes in psoriasis

Jiayin Zhang 1
,
Jiaqi Shi 1
,
Mi Zhong 1

  1. Department of Dermatology, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, China

Adv Dermatol Allergol 2026; XLIII (4): 410-425

DOI: https://doi.org/10.5114/ada.2026.164263
Data publikacji online: 2026/09/14
Article file
PDiA Integrated.pdf
  1. Boehncke WH, Schön MP. Psoriasis. Lancet 2015; 386: 983-94.
  2. Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker JNWN. Psoriasis. Lancet 2021; 397: 1301-15.
  3. Rendon A, Schäkel K. Psoriasis pathogenesis and treatment. Int J Mol Sci 2019; 20: 1475.
  4. Maity P, Singh K, Krug L, et al. Persistent JunB activation in fibroblasts disrupts stem cell niche interactions enforcing skin aging. Cell Rep 2021; 36: 109634.
  5. Smith NP, Yan Y, Pan Y, et al. Resident memory T cell development is associated with AP-1 transcription factor upregulation across anatomical niches. BioRxiv 2023; 2023.09.29.560006.
  6. Uluçkan Ö, Guinea-Viniegra J, Jimenez M, Wagner EF. Signalling in inflammatory skin disease by AP-1 (Fos/Jun). Clin Exp Rheumatol 2015; 33 (4 Suppl 92): S44-9.
  7. Gou C, Ni W, Ma P, et al. The endoribonuclease N4BP1 prevents psoriasis by controlling both keratinocytes proliferation and neutrophil infiltration. Cell Death Dis 2021; 12: 488.
  8. Zhao X, Xing J, Li J, et al. Dysregulated dermal mesenchymal stem cell proliferation and differentiation interfered by glucose metabolism in psoriasis. Int J Stem Cells 2021; 14: 85-93.
  9. Park CC, Kim KJ, Eoo SY, et al. Comparison of the expression profile of JunB, c-Jun, and S100A8 (Calgranulin A) in psoriasis vulgaris and guttate psoriasis. Ann Dermatol 2009; 21: 35-8.
  10. Uluçkan Ö, Jiménez M, Roediger B, et al. Cutaneous immune cell-microbiota interactions are controlled by epidermal JunB/AP-1. Cell Rep 2019; 29: 844-59.e3.
  11. Ren FJ, Cai XY, Yao Y, Fang GY. JunB: a paradigm for Jun family in immune response and cancer. Front Cell Infect Microbiol 2023; 13: 1222265.
  12. Pi Z, Qiu X, Liu J, et al. Activating protein-1 (AP-1): a promising target for the treatment of fibrotic diseases. Curr Med Chem 2023; doi: 10.2174/0929867330666230209100059.
  13. Zhang X, Jin JY, Wu J, et al. RNA-Seq and ChIP-Seq reveal SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation. J Investig Dermatol 2015; 135: 1016-24.
  14. Koizumi SI, Sasaki D, Hsieh TH, et al. JunB regulates homeostasis and suppressive functions of effector regulatory T cells. Nat Commun 2018; 9: 5344.
  15. Fu L, Li M, Wang P, et al. Tanshinone IIA, a component of the self-made Xiao-Yin decoction, ameliorates psoriasis by inhibiting IL-17/IL-23 and PTGS2/NF-kB/AP-1 pathways. Skin Res Technol 2024; 30: e13577.
  16. Kurtoviæ M, Pitesa N, Conkas J, et al. GLI transcriptional targets S100A7 and KRT16 show upregulated expression patterns in epidermis overlying the tumor mass in melanoma samples. Int J Mol Sci 2024; 25: 6084.
  17. Granata M, Skarmoutsou E, Gangemi P, et al. S100A7, Jab1, and p27kip1 expression in psoriasis and S100A7 CRISPR-activated human keratinocyte cell line. J Cell Biochem 2019; 120: 3384-92.
  18. Dajnoki Z, Somogyi O, Medgyesi B, et al. Primary alterations during the development of hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2022; 36: 462-71.
  19. Lu Z, Zheng S, Liu C, et al. S100A7 as a potential diagnostic and prognostic biomarker of esophageal squamous cell carcinoma promotes M2 macrophage infiltration and angiogenesis. Clin Transl Med 2021; 11: e459.
  20. Onderdijk AJ, Baerveldt EM, Kurek D, et al. IL-4 downregulates IL-1b and IL-6 and induces GATA3 in psoriatic epidermal cells: route of action of a Th2 cytokine. J Immunol 2015; 195: 1744-52.
Copyright: © 2026 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
SUBMIT YOUR PAPER
Share
without publication fees
Indexed in
pubmed
Integrated with
integrated with publons
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications